These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8924667)
1. [The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma]. Tomczak R; Rieber A; Zeitler H; Rilinger N; Kreienberg R; Brambs HJ Rofo; 1996 Aug; 165(2):148-51. PubMed ID: 8924667 [TBL] [Abstract][Full Text] [Related]
2. Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Belli P; Costantini M; Romani M; Pastore G Rays; 2002; 27(4):299-305. PubMed ID: 12696292 [TBL] [Abstract][Full Text] [Related]
3. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. Rieber A; Tomczak RJ; Mergo PJ; Wenzel V; Zeitler H; Brambs HJ J Comput Assist Tomogr; 1997; 21(1):128-32. PubMed ID: 9022784 [TBL] [Abstract][Full Text] [Related]
4. [MR mammography at 0.5 tesla. I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T]. Kuhl CK; Kreft BP; Hauswirth A; Elevelt A; Steudel A; Reiser M; Schild HH Rofo; 1995 May; 162(5):381-9. PubMed ID: 7772759 [TBL] [Abstract][Full Text] [Related]
8. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography]. Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Preda L; Villa G; Rizzo S; Bazzi L; Origgi D; Cassano E; Bellomi M Breast Cancer Res; 2006; 8(5):R53. PubMed ID: 16959028 [TBL] [Abstract][Full Text] [Related]
10. [Dynamic MR mammography: is the course of signal intensification suitable for the differentiation of different forms of mastopathy?]. Sittek H; Kessler M; Heuck AF; Lebeau A; Kohnert M; Untch M; Bohmert H; Reiser M Rofo; 1996 Jul; 165(1):59-63. PubMed ID: 8765364 [TBL] [Abstract][Full Text] [Related]
11. Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma. Erozgen F; Ersoy YE; Akaydin M; Memmi N; Celik AS; Celebi F; Guzey D; Kaplan R Breast Cancer Res Treat; 2010 Sep; 123(2):447-52. PubMed ID: 20625813 [TBL] [Abstract][Full Text] [Related]
13. [Inflammatory lesions of the breast: indication for MR-mammography?]. Fischer U; Vosshenrich R; von Heyden D; Knipper H; Oestmann JW; Grabbe E Rofo; 1994 Oct; 161(4):307-11. PubMed ID: 7948976 [TBL] [Abstract][Full Text] [Related]
14. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound. Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554 [TBL] [Abstract][Full Text] [Related]
15. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425 [TBL] [Abstract][Full Text] [Related]
16. [Dynamic 3D MR mammography using a rapid gradient-echo sequence]. Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394 [TBL] [Abstract][Full Text] [Related]
17. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. Linda A; Zuiani C; Londero V; Bazzocchi M Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249 [TBL] [Abstract][Full Text] [Related]
18. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T]. Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960 [TBL] [Abstract][Full Text] [Related]
19. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences]. Dannert S; Krück W; Schick F; Claussen CD; Müller-Schimpfle M Rofo; 2001 Jan; 173(1):38-43. PubMed ID: 11225415 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography. Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]